The label expansion will include adults with AChR-Ab-negative gMG, making efgartigimod the first and only approved treatment for all serotypes of the rare neuromuscular disease.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/fda-expands-vyvgart-approval-all-adults-gmg-2026a1000fc1?src=rss
Author :
Publish date : 2026-05-12 13:19:00
Copyright for syndicated content belongs to the linked Source.
